Corrigendum to “Tetrazolium–based colorimetric assays underestimat the direct antitumor effects of bevacizumab” [Toxicology in vitro 91 (2023) 105631]

ElsevierVolume 107, August 2025, 106061Toxicology in VitroAuthor links open overlay panelPei Wei a, Min Wang b, Mao Lin c, Zhiyong Wang aShow morePrevious article in issueNext article in issue

Recommended articles

View Abstract

© 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

View original article
TOXICOLOGY IN VITRO

Comments (0)

No login
gif
format_indent_decrease